Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
Breast Cancer Res Treat. 2024 Apr;204(2):237-248. doi: 10.1007/s10549-023-07165-x. Epub 2023 Dec 19.
Breast Cancer Res Treat. 2024.
PMID: 38112922
Free PMC article.
Clinical Trial.
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer.
Petrova MP, Donev IS, Radanova MA, Eneva MI, Dimitrova EG, Valchev GN, Minchev VT, Taushanova MS, Boneva MV, Karanikolova TS, Gencheva RB, Zhbantov GA, Ivanova AI, Timcheva CV, P Pavlov B, Megdanova VG, Robev BS, Conev NV.
Petrova MP, et al. Among authors: timcheva cv.
Clin Exp Immunol. 2020 Dec;202(3):353-362. doi: 10.1111/cei.13505. Epub 2020 Aug 26.
Clin Exp Immunol. 2020.
PMID: 32757277
Free PMC article.
Item in Clipboard
Neutrophil to lymphocyte ratio as a potential predictive marker for treatment with pembrolizumab as a second line treatment in patients with non-small cell lung cancer.
Petrova MP, Eneva MI, Arabadjiev JI, Conev NV, Dimitrova EG, Koynov KD, Karanikolova TS, Valev SS, Gencheva RB, Zhbantov GA, Ivanova AI, Sarbianova II, Timcheva CV, Donev IS.
Petrova MP, et al. Among authors: timcheva cv.
Biosci Trends. 2020 Mar 16;14(1):48-55. doi: 10.5582/bst.2019.01279. Epub 2020 Feb 4.
Biosci Trends. 2020.
PMID: 32023563
Free article.
Item in Clipboard
Does verapamil help overcome multidrug resistance in tumor cell lines and cancer patients?
Timcheva CV, Todorov DK.
Timcheva CV, et al.
J Chemother. 1996 Aug;8(4):295-9. doi: 10.1179/joc.1996.8.4.295.
J Chemother. 1996.
PMID: 8873836
Clinical Trial.
Item in Clipboard
Cite
Cite